The Impact of Holding on Stress & Bonding in Mother-Infant Pairs During

Status Completed

Clinical Trial Summary

This research is being done to try to improve the experience of mothers and babies during therapeutic hypothermia. Currently, mothers are not able to hold their baby during hypothermia treatment. Mothers have reported that not being able to hold their baby during this time is stressful. Additionally, it is known that holding has many benefits for mothers' and babies' psychological and physical health. Therapeutic hypothermia is the standard of care. The experimental interventions of this study are to have mothers hold their babies during this treatment, collect saliva samples from mothers and babies, and test the saliva samples for the hormones cortisol and oxytocin. The investigators will test saliva of infants and their mothers before and after holding. The investigators hope to demonstrate decreased cortisol, a marker for stress, and increased oxytocin, a marker for bonding, in infants and mothers while they are held during therapeutic hypothermia.

Clinical Trial Description

The inability to hold an infant being treated with therapeutic hypothermia in the neonatal intensive care unit has been subjectively reported by ours and other research groups as a significant source of stress for parents. The investigators aim to assess the impact of holding on endocrinological markers of stress and bonding. Specifically, the investigators plan to collect salivary cortisol and oxytocin levels from infants undergoing therapeutic hypothermia and their mothers prior to and immediately after a 30-minute holding period. The investigators hypothesize that measurable increases in salivary oxytocin levels, coinciding with the reported qualitative increased levels of bonding, will be observed after the holding period. The investigators anticipate the reported stress reduction after holding to be quantified by measurable decreases in salivary cortisol levels. The investigators hypothesize these hormone changes will be present in both the mother and the infant when compared to samples taken without the holding intervention. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03837717
Study type	Interventional
Source	MaineHealth
Contact
Status	Completed
Phase	N/A
Start date	December 4, 2018
Completion date	February 8, 2021

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05048550` - Babies in Glasses; a Feasibility Study.	N/A
Recruiting	`NCT05514340` - Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy	Phase 2
Recruiting	`NCT05836610` - Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates	Phase 4
Completed	`NCT03024021` - Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
Completed	`NCT01913340` - Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)	Phase 1/Phase 2
Enrolling by invitation	`NCT02260271` - Florida Neonatal Neurologic Network
Terminated	`NCT01192776` - Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)	N/A
Completed	`NCT06344286` - The Effects of Minimal Enteral Nutrition on Mesenteric Blood Flow and Oxygenation in Neonates With HIE	N/A
Recruiting	`NCT05901688` - Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
Recruiting	`NCT02894866` - Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy	N/A
Recruiting	`NCT03657394` - Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries	N/A
Recruiting	`NCT03682042` - Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up	N/A
Withdrawn	`NCT03681314` - Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU)	N/A
Completed	`NCT03485781` - Propofol-induced EEG Changes in Hypoxic Brain Injury
Recruiting	`NCT05568264` - Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit	N/A
Completed	`NCT02264808` - Developmental Outcomes
Completed	`NCT05687708` - Effect of Non-nutritive Sucking on Transition to Oral Feeding in Infants With Asphyxia	N/A
Recruiting	`NCT06195345` - Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
Withdrawn	`NCT05295784` - PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia	Phase 1
Completed	`NCT01793129` - Preemie Hypothermia for Neonatal Encephalopathy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Impact of Holding on Stress and Bonding in Mother-Infant Pairs During Therapeutic Hypothermia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms